These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 23169235

  • 21. Correlation between echocardiographic left ventricular mass index and electrocardiographic variables used in left ventricular hypertrophy criteria in Chinese hypertensive patients.
    Xie L, Wang Z.
    Hellenic J Cardiol; 2010; 51(5):391-401. PubMed ID: 20876051
    [Abstract] [Full Text] [Related]

  • 22. Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study.
    Rodrigues SL, Angelo LC, Baldo MP, Dantas EM, Barcelos AM, Pereira AC, Krieger JE, Mill JG.
    Clin Res Cardiol; 2013 Sep; 102(9):653-9. PubMed ID: 23660930
    [Abstract] [Full Text] [Related]

  • 23. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlöf B.
    Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
    [Abstract] [Full Text] [Related]

  • 24. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J, for Investigators study VIIDA.
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [Abstract] [Full Text] [Related]

  • 25. Visceral fat level correction of the left ventricular hypertrophy electrocardiographic criteria.
    Salamaga S, Dydowicz F, Turowska A, Juszczyk I, Matyjasek M, Kostka-Jeziorny K, Szczepaniak-Chicheł L, Tykarski A, Uruski P.
    Ann Noninvasive Electrocardiol; 2021 Nov; 26(6):e12863. PubMed ID: 34114298
    [Abstract] [Full Text] [Related]

  • 26. Cornell product in an electrocardiogram is related to reduced LV regional wall motion.
    Ishikawa J, Yamanaka Y, Watanabe S, Toba A, Harada K.
    Hypertens Res; 2019 Apr; 42(4):541-548. PubMed ID: 30542082
    [Abstract] [Full Text] [Related]

  • 27. Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity.
    Okin PM, Roman MJ, Devereux RB, Kligfield P.
    J Am Coll Cardiol; 1996 Jan; 27(1):124-31. PubMed ID: 8522685
    [Abstract] [Full Text] [Related]

  • 28. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements.
    Sosnowski M, Korzeniowska B, Tendera M.
    Int J Cardiol; 2006 Jan 26; 106(3):382-9. PubMed ID: 15996771
    [Abstract] [Full Text] [Related]

  • 29. Diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy among various body mass index groups compared to diagnosis by cardiac magnetic resonance imaging.
    Nomsawadi V, Krittayaphong R.
    Ann Noninvasive Electrocardiol; 2019 Jul 26; 24(4):e12635. PubMed ID: 30719815
    [Abstract] [Full Text] [Related]

  • 30. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy.
    Oikonomou E, Theofilis P, Mpahara A, Lazaros G, Niarchou P, Vogiatzi G, Tsalamandris S, Fountoulakis P, Christoforatou E, Mystakidou V, Anastasiou M, Goliopoulou A, Tousoulis D.
    Ann Noninvasive Electrocardiol; 2020 May 26; 25(3):e12728. PubMed ID: 31724804
    [Abstract] [Full Text] [Related]

  • 31. [Value of the electrocardiographic Cornell criteria for detecting left ventricular hypertrophy in elderly men].
    Zeng XZ, Liu DP, He Q, Guo HL, Fang F, Liu DG, Dong R, Zeng HY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan 26; 37(1):56-8. PubMed ID: 19671355
    [Abstract] [Full Text] [Related]

  • 32. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D, Chrysohoou C, Oikonomou E, Lazaros G, Dimitriadis K, Maragiannis D, Roussos D, Andreou I, Tsantilas A, Christoforatou E, Pitsavos C, Panagiotakos D, Stefanadis C.
    J Hypertens; 2011 Aug 26; 29(8):1624-32. PubMed ID: 21610511
    [Abstract] [Full Text] [Related]

  • 33. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.
    Porthan K, Kenttä T, Niiranen TJ, Nieminen MS, Oikarinen L, Viitasalo M, Hernesniemi J, Jula AM, Salomaa V, Huikuri HV, Albert CM, Tikkanen JT.
    Int J Cardiol; 2019 Feb 01; 276():125-129. PubMed ID: 30293667
    [Abstract] [Full Text] [Related]

  • 34. Peguero-Lo Presti criteria for the diagnosis of left ventricular hypertrophy: A systematic review and meta-analysis.
    Yu Z, Song J, Cheng L, Li S, Lu Q, Zhang Y, Lin X, Liu D.
    PLoS One; 2021 Feb 01; 16(1):e0246305. PubMed ID: 33513186
    [Abstract] [Full Text] [Related]

  • 35. Correlation of electrocardiographic left ventricular hypertrophy criteria with left ventricular mass by echocardiogram in obese hypertensive patients.
    da Costa W, Riera AR, Costa Fde A, Bombig MT, de Paola AA, Carvalho AC, Fonseca FH, Luna Filho B, Póvoa R.
    J Electrocardiol; 2008 Feb 01; 41(6):724-9. PubMed ID: 18954613
    [Abstract] [Full Text] [Related]

  • 36. Performance of Electrocardiographic Criteria for Echocardiographically Diagnosed Left Ventricular Hypertrophy in Chinese Hypertensive Patients.
    Wang D, Xu JZ, Zhang W, Chen Y, Li J, An Y, Bian R, Wang JG.
    Am J Hypertens; 2020 Sep 10; 33(9):831-836. PubMed ID: 32484222
    [Abstract] [Full Text] [Related]

  • 37. Performance of electrocardiographic criteria for detecting LVH in hypertensive Africans.
    Vandroux D, Amidou S, Sarki SI, Magne J, Houehanou YC, Chastaingt L, Aboyans V, Lacroix P, TAHES study investigators.
    J Electrocardiol; 2024 Sep 10; 86():153773. PubMed ID: 39173469
    [Abstract] [Full Text] [Related]

  • 38. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM, Devereux RB, Jern S, Julius S, Kjeldsen SE, Dahlöf B.
    Am J Hypertens; 2001 Aug 10; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [Abstract] [Full Text] [Related]

  • 39. QT intervals and QT dispersion as measures of left ventricular hypertrophy in an unselected hypertensive population.
    Chapman N, Mayet J, Ozkor M, Lampe FC, Thom SA, Poulter NR.
    Am J Hypertens; 2001 May 10; 14(5 Pt 1):455-62. PubMed ID: 11368467
    [Abstract] [Full Text] [Related]

  • 40. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.
    Agarwal R, Light RP.
    Clin J Am Soc Nephrol; 2011 Mar 10; 6(3):528-36. PubMed ID: 21088286
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.